nimustine has been researched along with Hemorrhagic Thrombocythemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasai, M; Natsume, S; Satake, T; Shimokawa, T; Takeyama, H; Watanabe, E; Yamada, H | 1 |
| Bandoh, S; Fujita, M; Funamoto, Y; Kuwabara, H; Nagai, M; Takahara, J; Tasaka, T; Yamaoka, G; Yamauchi, A | 1 |
2 other study(ies) available for nimustine and Hemorrhagic Thrombocythemia
| Article | Year |
|---|---|
[Essential thrombocythemia clinical characteristics and course of 10 cases].
Topics: Adolescent; Adult; Aged; Bone Marrow; Female; Humans; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Thrombocythemia, Essential | 1994 |
Secondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia.
Topics: Antigens, CD; Cell Transformation, Neoplastic; Humans; Immunophenotyping; Killer Cells, Natural; Leukemia, Myeloid; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Thrombocythemia, Essential | 1999 |